Taysha Gene Therapies, Inc. Common Stock (TSHA) News

Latest headlines that mention TSHA, newest first · each headline opens the original publisher

TSHA quote

Last price: $4.01
Day change: +1.26%
Next earnings: 2026-11-03

Quote & chart Expected move Insider trading IV rank history

TSHA headlines

latest coverage

Investing.com 13d ago

Taysha Gene Therapies stock hits 52-week low at 3.69 USD

General T3TSHA

Seeking Alpha News 1mo ago

Taysha Gene Therapies: A Bull Case That Does Not Require The Fastest Approval

General T2TSHA

Motley Fool 2mo ago

Taysha Gene Therapies (TSHA) Q2 2026 Earnings Call

TSHA-102 dosing complete in pivotal Rett syndrome trials with 100% responder rate.

Earnings T3TSHA

Seeking Alpha News 2mo ago

Taysha Gene Therapies, Inc. (TSHA) Q2 2026 Earnings Call Transcript

Earnings T2TSHA

Seeking Alpha 2mo ago

Taysha Gene Therapies GAAP EPS of -$0.13 misses by $0.01

Earnings T2TSHA

Yahoo Finance 3mo ago

Taysha Gene Therapies (TSHA) is One of The Most Affordable Biotech Names to Invest In

General T2TSHA

Investing.com 3mo ago

Taysha Gene Therapies president sells $1.25m in stock

General T3TSHA

Investing.com 3mo ago

Form 144 Taysha Gene Therapies For: 10 July

General T3TSHA

Investing.com 3mo ago

Citizens reiterates Taysha Gene Therapies stock rating on therapy progress

General T3TSHA

Investing.com 4mo ago

Taysha Gene Therapies to present Rett syndrome data at conference

General T3TSHA

Investing.com 4mo ago

Taysha Gene Therapies stock tumbles on public offering pricing

General T3TSHA

Seeking Alpha 4mo ago

Taysha Gene Therapies shares tumble following pricing shares at $6.00 to raise $200M

General T2TSHA

Seeking Alpha 4mo ago

Taysha Gene Therapies launches $200M public offering; shares down

General T2TSHA

Investing.com 4mo ago

Taysha Gene Therapies stock tumbles on $200M stock offering

General T3TSHA

Seeking Alpha News 4mo ago

Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome - Slideshow

General T2TSHA

Investing.com 4mo ago

Citizens raises Taysha Gene Therapies price target on trial data

General T3TSHA

Seeking Alpha News 4mo ago

Taysha Gene Therapies, Inc. (TSHA) Discusses Longer-Term Clinical Data and Program Update for TSHA-102 in Rett Syndrome Transcript

General T2TSHA

Investing.com 4mo ago

Taysha Gene Therapies stock price target raised to $10 by BofA on trial data

General T3TSHA

Yahoo Finance 4mo ago

Is Taysha Gene Therapies, Inc. (TSHA) A Good Stock To Buy Now?

General T2TSHA

Seeking Alpha News 4mo ago

Taysha Gene Therapies: Shortened Timeline Increases The Potential

General T2TSHA

Investing.com 5mo ago

Taysha Gene Therapies stock hits all-time high at 5.49 USD

General T3TSHA

Investing.com 5mo ago

Taysha Gene Therapies’ SWOT analysis: stock faces pivotal trial test

General T3TSHA

Yahoo Finance 5mo ago

Taysha Gene Therapies (TSHA) Reports Financial Results for Q1 2026

General T2TSHA

Yahoo Finance 5mo ago

Canaccord Keeps Buy Rating on Taysha (TSHA) After Q1 Highlights

General T2TSHA

Motley Fool 5mo ago

Taysha (TSHA) Q1 2026 Earnings Transcript

Image source: The Motley Fool. Wednesday, May 6, 2026 at 8:30 a.m. ET Need a quote from a Motley Fool analyst? Email pr@fool.com Continue reading

Earnings T3TSHA

Seeking Alpha News 5mo ago

Taysha Gene Therapies, Inc. (TSHA) Q1 2026 Earnings Call Transcript

Earnings T2TSHA

TSHA news alerts

Get an alert by email or push when a new headline mentions TSHA.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.